These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

272 related items for PubMed ID: 9547230

  • 21. Acetylcholinesterase, a senile plaque component, affects the fibrillogenesis of amyloid-beta-peptides.
    Alvarez A, Bronfman F, Pérez CA, Vicente M, Garrido J, Inestrosa NC.
    Neurosci Lett; 1995 Dec 01; 201(1):49-52. PubMed ID: 8830310
    [Abstract] [Full Text] [Related]

  • 22. How do membranes initiate Alzheimer's Disease? Formation of toxic amyloid fibrils by the amyloid β-protein on ganglioside clusters.
    Matsuzaki K.
    Acc Chem Res; 2014 Aug 19; 47(8):2397-404. PubMed ID: 25029558
    [Abstract] [Full Text] [Related]

  • 23. Neuronal pentraxin 1 contributes to the neuronal damage evoked by amyloid-beta and is overexpressed in dystrophic neurites in Alzheimer's brain.
    Abad MA, Enguita M, DeGregorio-Rocasolano N, Ferrer I, Trullas R.
    J Neurosci; 2006 Dec 06; 26(49):12735-47. PubMed ID: 17151277
    [Abstract] [Full Text] [Related]

  • 24. In vitro studies of amyloid beta-protein fibril assembly and toxicity provide clues to the aetiology of Flemish variant (Ala692-->Gly) Alzheimer's disease.
    Walsh DM, Hartley DM, Condron MM, Selkoe DJ, Teplow DB.
    Biochem J; 2001 May 01; 355(Pt 3):869-77. PubMed ID: 11311152
    [Abstract] [Full Text] [Related]

  • 25. Changes in readthrough acetylcholinesterase expression modulate amyloid-beta pathology.
    Berson A, Knobloch M, Hanan M, Diamant S, Sharoni M, Schuppli D, Geyer BC, Ravid R, Mor TS, Nitsch RM, Soreq H.
    Brain; 2008 Jan 01; 131(Pt 1):109-19. PubMed ID: 18056160
    [Abstract] [Full Text] [Related]

  • 26. [Alzheimer disease: cellular and molecular aspects].
    Octave JN.
    Bull Mem Acad R Med Belg; 2005 Jan 01; 160(10-12):445-9; discussion 450-1. PubMed ID: 16768248
    [Abstract] [Full Text] [Related]

  • 27. Toxicity of non-abeta component of Alzheimer's disease amyloid, and N-terminal fragments thereof, correlates to formation of beta-sheet structure and fibrils.
    Bodles AM, Guthrie DJ, Harriott P, Campbell P, Irvine GB.
    Eur J Biochem; 2000 Apr 01; 267(8):2186-94. PubMed ID: 10759841
    [Abstract] [Full Text] [Related]

  • 28. Silibinin inhibits acetylcholinesterase activity and amyloid β peptide aggregation: a dual-target drug for the treatment of Alzheimer's disease.
    Duan S, Guan X, Lin R, Liu X, Yan Y, Lin R, Zhang T, Chen X, Huang J, Sun X, Li Q, Fang S, Xu J, Yao Z, Gu H.
    Neurobiol Aging; 2015 May 01; 36(5):1792-807. PubMed ID: 25771396
    [Abstract] [Full Text] [Related]

  • 29. Acetylcholinesterase accelerates assembly of amyloid-beta-peptides into Alzheimer's fibrils: possible role of the peripheral site of the enzyme.
    Inestrosa NC, Alvarez A, Pérez CA, Moreno RD, Vicente M, Linker C, Casanueva OI, Soto C, Garrido J.
    Neuron; 1996 Apr 01; 16(4):881-91. PubMed ID: 8608006
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. 6-Methyluracil derivatives as acetylcholinesterase inhibitors for treatment of Alzheimer's disease.
    Zueva IV, Semenov VE, Mukhamedyarov MA, Lushchekina SV, Kharlamova AD, Petukhova EO, Mikhailov AS, Podyachev SN, Saifina LF, Petrov KA, Minnekhanova OA, Zobov VV, Nikolsky EE, Masson P, Reznik VS.
    Int J Risk Saf Med; 2015 Apr 01; 27 Suppl 1():S69-71. PubMed ID: 26639718
    [Abstract] [Full Text] [Related]

  • 32. Interactions of AChE with Aβ Aggregates in Alzheimer's Brain: Therapeutic Relevance of IDN 5706.
    Carvajal FJ, Inestrosa NC.
    Front Mol Neurosci; 2011 Apr 01; 4():19. PubMed ID: 21949501
    [Abstract] [Full Text] [Related]

  • 33. Alzheimer's disease amyloid β-protein mutations and deletions that define neuronal binding/internalization as early stage nonfibrillar/fibrillar aggregates and late stage fibrils.
    Poduslo JF, Howell KG, Olson NC, Ramirez-Alvarado M, Kandimalla KK.
    Biochemistry; 2012 May 15; 51(19):3993-4003. PubMed ID: 22545812
    [Abstract] [Full Text] [Related]

  • 34. Effects of a tacrine-8-hydroxyquinoline hybrid (IQM-622) on Aβ accumulation and cell death: involvement in hippocampal neuronal loss in Alzheimer's disease.
    Antequera D, Bolos M, Spuch C, Pascual C, Ferrer I, Fernandez-Bachiller MI, Rodríguez-Franco MI, Carro E.
    Neurobiol Dis; 2012 Jun 15; 46(3):682-91. PubMed ID: 22426395
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Interaction of metal chelators with different molecular forms of acetylcholinesterase and its significance in Alzheimer's disease treatment.
    Chitra L, Kumar CR, Basha HM, Ponne S, Boopathy R.
    Proteins; 2013 Jul 15; 81(7):1179-91. PubMed ID: 23408593
    [Abstract] [Full Text] [Related]

  • 37. A new motif in the N-terminal of acetylcholinesterase triggers amyloid-β aggregation and deposition.
    Hou LN, Xu JR, Zhao QN, Gao XL, Cui YY, Xu J, Wang H, Chen HZ.
    CNS Neurosci Ther; 2014 Jan 15; 20(1):59-66. PubMed ID: 23981668
    [Abstract] [Full Text] [Related]

  • 38. New racemic annulated pyrazolo[1,2-b]phthalazines as tacrine-like AChE inhibitors with potential use in Alzheimer's disease.
    Jalili-Baleh L, Nadri H, Moradi A, Bukhari SNA, Shakibaie M, Jafari M, Golshani M, Homayouni Moghadam F, Firoozpour L, Asadipour A, Emami S, Khoobi M, Foroumadi A.
    Eur J Med Chem; 2017 Oct 20; 139():280-289. PubMed ID: 28803044
    [Abstract] [Full Text] [Related]

  • 39. Physicochemical characteristics of soluble oligomeric Abeta and their pathologic role in Alzheimer's disease.
    Watson D, Castaño E, Kokjohn TA, Kuo YM, Lyubchenko Y, Pinsky D, Connolly ES, Esh C, Luehrs DC, Stine WB, Rowse LM, Emmerling MR, Roher AE.
    Neurol Res; 2005 Dec 20; 27(8):869-81. PubMed ID: 16354549
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.